Significance: Regulatory T (Treg) cells mediate immune homeostasis, aid in tissue repair, and resolve inflammation in numerous autoimmune diseases; however, little is known about the role of Treg cell motility dynamics in immunoregulation. We imaged the organization and motility patterns of endogenous Treg cells in the spinal cord together with pathogenic Th17 cells in a mouse model of neuroinflammation. Treg cells exhibit repetitive-scanning motility, which may be important in suppressing Th17 cell effector functions by inhibition of Ca 2+ signaling and by limiting their access to APCs, thus limiting their reactivation in the spinal cord. These findings will help to understand how Treg cells prevent autoimmunity and dampen immune responses, and how autoimmune diseases can be effectively targeted using Treg-based cellular therapies.
Introduction . Epileptic seizures are common neurological disorders in the world, impacting 65 million people globally. Around 30% of patients with seizures suffer from refractory epilepsy, where seizures are not controlled by medications. The unpredictability of seizures makes it essential to have a continuous seizure monitoring system outside clinical settings for the purpose of minimizing patients’ injuries and providing additional pathways for evaluation and treatment follow-up. Autonomic changes related to seizure events have been extensively studied and attempts made to apply them for seizure detection and prediction tasks. This scoping review aims to depict current research activities associated with the implementation of portable, wearable devices for seizure detection or prediction and inform future direction in continuous seizure tracking in ambulatory settings. Methods . Overall methodology framework includes 5 essential stages: research questions identification, relevant studies identification, selection of studies, data charting and summarizing the findings. A systematic searching strategy guided by systematic reviews and meta-analysis (PRISMA) was implemented to identify relevant records on two databases (PubMed, IEEE). Results . A total of 30 articles were included in our final analysis. Most of the studies were conducted off-line and employed consumer-graded wearable device. ACM is the dominant modality to be used in seizure detection, and widely deployed algorithms entail Support Vector Machine, Random Forest and threshold-based approach. The sensitivity ranged from 33.2% to 100% for single modality with a false alarm rate (FAR) ranging from 0.096 to 14.8 d −1 . Multimodality has a sensitivity ranging from 51% to 100% with FAR ranging from 0.12 to 17.7 d −1 . Conclusion . The overall performance in seizure detection system based on non-cerebral physiological signals is promising, especially for the detection of motor seizures and seizures accompanied with intense ictal autonomic changes.
Patients with rare diseases often experience prolonged diagnostic delays. Ordering appropriate genetic tests is crucial yet challenging, especially for general pediatricians without genetic expertise. Recent American College of Medical Genetics (ACMG) guidelines embrace early use of exome sequencing (ES) or genome sequencing (GS) for conditions like congenital anomalies or developmental delays while still recommend gene panels for patients exhibiting strong manifestations of a specific disease. Recognizing the difficulty in navigating these options, we developed a machine learning model trained on 1005 patient records from Columbia University Irving Medical Center to recommend appropriate genetic tests based on the phenotype information. The model achieved a remarkable performance with an AUROC of 0.823 and AUPRC of 0.918, aligning closely with decisions made by genetic specialists, and demonstrated strong generalizability (AUROC:0.77, AUPRC: 0.816) in an external cohort, indicating its potential value for general pediatricians to expedite rare disease diagnosis by enhancing genetic test ordering.
17 January 2025 in Journal of the American Medical Informatics Association
Objective: Extracting PICO elements—Participants, Intervention, Comparison, and Outcomes—from clinical trial literature is essential for clinical evidence retrieval, appraisal, and synthesis. Existing approaches do not distinguish the attributes of PICO entities. This study aims to develop a named entity recognition (NER) model to extract PICO entities with fine granularities. Materials and Methods: Using a corpus of 2511 abstracts with PICO mentions from 4 public datasets, we developed a semi-supervised method to facilitate the training of a NER model, FinePICO, by combining limited annotated data of PICO entities and abundant unlabeled data. For evaluation, we divided the entire dataset into 2 subsets: a smaller group with annotations and a larger group without annotations. We then established the theoretical lower and upper performance bounds based on the performance of supervised learning models trained solely on the small, annotated subset and on the entire set with complete annotations, respectively. Finally, we evaluated FinePICO on both the smaller annotated subset and the larger, initially unannotated subset. We measured the performance of FinePICO using precision, recall, and F1. Results: Our method achieved precision/recall/F1 of 0.567/0.636/0.60, respectively, using a small set of annotated samples, outperforming the baseline model (F1: 0.437) by more than 16%. The model demonstrates generalizability to a different PICO framework and to another corpus, which consistently outperforms the benchmark in diverse experimental settings (P-value < .001). Discussion: We developed FinePICO to recognize fine-grained PICO entities from text and validated its performance across diverse experimental settings, highlighting the feasibility of using semi-supervised learning (SSL) techniques to enhance PICO entities extraction. Future work can focus on optimizing SSL algorithms to improve efficiency and reduce computational costs. Conclusion: This study contributes a generalizable and effective semi-supervised approach leveraging large unlabeled data together with small, annotated data for fine-grained PICO extraction.
9 November 2024 in Journal of the American Medical Informatics Association
Objective: This study aims to automate the prediction of Mini-Mental State Examination (MMSE) scores, a widely adopted standard for cognitive assessment in patients with Alzheimer’s disease, using natural language processing (NLP) and machine learning (ML) on structured and unstructured EHR data. Materials and Methods: We extracted demographic data, diagnoses, medications, and unstructured clinical visit notes from the EHRs. We used Latent Dirichlet Allocation (LDA) for topic modeling and Term-Frequency Inverse Document Frequency (TF-IDF) for n-grams. In addition, we extracted meta-features such as age, ethnicity, and race. Model training and evaluation employed eXtreme Gradient Boosting (XGBoost), Stochastic Gradient Descent Regressor (SGDRegressor), and Multi-Layer Perceptron (MLP). Results: We analyzed 1654 clinical visit notes collected between September 2019 and June 2023 for 1000 Alzheimer’s disease patients. The average MMSE score was 20, with patients averaging 76.4 years old, 54.7% female, and 54.7% identifying as White. The best-performing model (ie, lowest root mean squared error (RMSE)) is MLP, which achieved an RMSE of 5.53 on the validation set using n-grams, indicating superior prediction performance over other models and feature sets. The RMSE on the test set was 5.85. Discussion: This study developed a ML method to predict MMSE scores from unstructured clinical notes, demonstrating the feasibility of utilizing NLP to support cognitive assessment. Future work should focus on refining the model and evaluating its clinical relevance across diverse settings. Conclusion: We contributed a model for automating MMSE estimation using EHR features, potentially transforming cognitive assessment for Alzheimer’s patients and paving the way for more informed clinical decisions and cohort identification.
Autism exhibits substantial phenotypic heterogeneity, yet age‐dependent variation in phenotypic profiles and onset timing remains poorly understood. We aimed to characterize stage‐specific phenotypes and temporal onset patterns of autism using longitudinal electronic health records (EHRs). We analyzed EHR data from Columbia University Irving Medical Center. Autism cases were stratified by age at diagnosis. Phenotype enrichment analyses were performed using chi‐square and Fisher's exact tests to identify phenotypes overrepresented in autism cases compared with matched controls, and temporal patterns of phenotype onset were subsequently evaluated to identify stage‐specific clinical signatures and provide insight into differences between early‐ and late‐diagnosed individuals. Among 4818 cases and 1433 phenotypes, 195 and 155 were enriched in toddlerhood and adolescence groups. Early diagnosed individuals exhibited a higher prevalence of sensory‐related conditions, greater exposure to maternal and perinatal complications than their matched controls (all ORs > 1; p < 0.01), and earlier onset of neurologic features, including coordination abnormalities and convulsions, compared with later‐diagnosed individuals. The study provides a publicly accessible resource to enrich autism‐related phenotypic profiles, uncovering notable phenotypic differences and variations in timing of phenotype onset between early‐diagnosed and later‐diagnosed individuals. These findings underscore phenotypic heterogeneity and highlight the need for age‐sensitive screening strategies. To our knowledge, this is among the first studies to jointly characterize phenotypic profiles and their temporal onset patterns across developmental stages in autism using longitudinal EHR data. These findings offer novel insights into age‐dependent clinical signatures, informing earlier and more precise screening strategies.